Medtronic Evolut TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years Medical Device Investing
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest Medical Device Investing
FDA Approves Cabtreo Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older Pharmaceutical Investing
Medtronic Earns Four 5-Star Ratings From the Hispanic Association on Corporate Responsibility Medical Device Investing
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics Medical Device Investing
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence Pharmaceutical Investing
Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business Medical Device Investing
Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil Pharmaceutical Investing
